Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene

被引:9
作者
Li, Yueyan [1 ,2 ]
Zheng, Rui [1 ,2 ]
Xu, Guofeng [1 ,2 ]
Huang, Yunteng [2 ,3 ]
Li, Yongmei [4 ,5 ]
Li, Dali [4 ,5 ]
Geng, Hongquan [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Pediat Urol, Sch Med, Xinhua Hosp, Shanghai, Peoples R China
[2] Natl Hlth & Family Planning Commiss Peoples Repub, Childrens Stone Treatment Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Urol, Shanghai, Peoples R China
[4] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China
[5] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
calcium oxalate; CRISPR/Cas9; hyperoxaluria; inflammation; necroptosis; GLYCOLATE OXIDASE; GENOMIC DNA; MOUSE MODEL; OXALOSIS; TRANSPLANTATION; MITOCHONDRIAL; DEPOSITION; CRYSTALS; THERAPY; UPDATE;
D O I
10.1152/ajprenal.00514.2020
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Primary hyperoxaluria type 1 (PH1) is a severe inherited disorder caused by a genetic defect in alanine-glyoxylate aminotransferase (AGXT), which results in recurrent urolithiasis and renal failure. Animal models that precisely reflect human PH1 phenotypes are lacking. We aimed to develop a novel PH1 rat model and study the mechanisms involved in PH1 deterioration. One cell stage Sprague-Dawley embryos were injected with the CRISPR/Cas9 system to introduce a Q84X mutation in Agxt. Liver tissues were harvested to determine Agxt expression. Urine oxalate, crystals, and electrolyte levels in Agxt(Q84X) and wild-type (WT) littermates were evaluated. Kidney tissues were used for Pizzolato staining and kidney injury evaluation. Data showed that Agxt mRNA and protein were absent in Agxt(Q84X) rats. At 4 and 24 wk, Agxt(Q84X) rats displayed 2.1- and 2.9-fold higher urinary oxalate levels, respectively, compared with WT littermates. As a result, calcium oxalate (CaOx) crystals in urine were revealed in all Agxt(Q84X) rats but in none of the WT rats. We also observed bladder stones in 36.4% of Agxt(Q84X) rats, of which 44.4% had renal CaOx deposition. Moreover, the elevated serum urea and creatinine levels indicated the impaired renal function in Agxt(Q84X) rats. Further investigation revealed significantly increased expression of inflammation-, necroptosis-, and fibrosis-related genes in the kidneys of Agxt(Q84X) rats with spontaneous renal CaOx deposition, indicating that these pathways are involved in PH1 deterioration. Collectively, these results suggest that this rat model has broad applicability in mechanistic studies and innovative therapeutics development for PH1 and other kidney stone diseases. NEW & NOTEWORTHY Primary hyperoxaluria type 1 is a severe inherited disorder that results in recurrent urolithiasis and renal failure. We generated an alanine-glyoxylate aminotransferase (Agxt)(Q84X) nonsense mutant rat model that displayed an early onset of hyperoxaluria, spontaneous renal CaOx precipitation, bladder stone, and kidney injuries. Our results suggest an interaction of renal CaOx crystals with the activation of inflammation-, fibrosis-, and necroptosis-related pathways. In all, the Agxt(Q84X) rat strain has broad applicability in mechanistic studies and the development of innovative therapeutics.
引用
收藏
页码:F475 / F484
页数:10
相关论文
共 43 条
  • [1] Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions
    Beck, Bodo B.
    Hoyer-Kuhn, Heike
    Goebel, Heike
    Habbig, Sandra
    Hoppe, Bernd
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (01) : 117 - 129
  • [2] Liver cell transplantation in severe infantile oxalosis-a potential bridging procedure to orthotopic liver transplantation?
    Beck, Bodo B.
    Habbig, Sandra
    Dittrich, Katalin
    Stippel, Dirk
    Kaul, Ingrid
    Koerber, Friederike
    Goebel, Heike
    Salido, Eduardo C.
    Kemper, Markus
    Meyburg, Jochen
    Hoppe, Bernd
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2984 - 2989
  • [3] Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways
    Danpure, Christopher J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2006, 1763 (12): : 1776 - 1784
  • [4] Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
    Dutta, Chaitali
    Avitahl-Curtis, Nicole
    Pursell, Natalie
    Cohen, Marita Larsson
    Holmes, Benjamin
    Diwanji, Rohan
    Zhou, Wei
    Apponi, Luciano
    Koser, Martin
    Ying, Bo
    Chen, Dongyu
    Shui, Xue
    Saxena, Utsav
    Cyr, Wendy A.
    Shah, Anee
    Nazef, Naim
    Wang, Weimin
    Abrams, Marc
    Dudek, Henryk
    Salido, Eduardo
    Brown, Bob D.
    Lai, Chengjung
    [J]. MOLECULAR THERAPY, 2016, 24 (04) : 770 - 778
  • [5] Intra-familial clinical heterogeneity: Absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel
    Frishberg, Y
    Rinat, C
    Shalata, A
    Khatib, I
    Feinstein, SA
    Becker-Cohen, R
    Weismann, I
    Wanders, RJA
    Rumsby, G
    Roels, F
    Mandel, H
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (03) : 269 - 275
  • [6] Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
    Gaudelli, Nicole M.
    Komor, Alexis C.
    Rees, Holly A.
    Packer, Michael S.
    Badran, Ahmed H.
    Bryson, David I.
    Liu, David R.
    [J]. NATURE, 2017, 551 (7681) : 464 - +
  • [7] PRIMARY HYPEROXALURIA AND OXALOSIS - REPORT OF A CASE AND REVIEW OF THE LITERATURE
    GODWIN, JT
    FOWLER, MF
    DEMPSEY, EF
    HENNEMAN, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1958, 259 (23) : 1099 - 1103
  • [8] CLINICAL MANIFESTATIONS OF PRIMARY HYPEROXALURIA
    HALL, EG
    SCOWEN, EF
    WATTS, RWE
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1960, 35 (179) : 108 - 112
  • [9] Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy
    Harambat, Jerome
    van Stralen, Karlun J.
    Espinosa, Laura
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Cerkauskiene, Rimante
    Schaefer, Franz
    Verrina, Enrico
    Jager, Kitty J.
    Cochat, Pierre
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03): : 458 - 465
  • [10] Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones
    He, Lei
    Xu, Guofeng
    Fang, Xiaoliang
    Lin, Houwei
    Xu, Maosheng
    Yu, Yongguo
    Geng, Hongquan
    [J]. WORLD JOURNAL OF UROLOGY, 2019, 37 (08) : 1713 - 1721